Authors:
Sdringola, S
Assali, AR
Ghani, M
Moustapha, A
Achour, H
Yusuf, SW
Fujise, K
Rosales, O
Schroth, GW
Anderson, HV
Smalling, RW
Citation: S. Sdringola et al., Risk assessment of slow or no-reflow phenomenon in aortocoronary vein graft percutaneous intervention, CATHET C IN, 54(3), 2001, pp. 318-324
Citation: S. Sdringola et al., Use of intracoronary adenosine for the management of slow-no-reflow phenomenon during percutaneous interventions - Reply to the letter, CATHET C IN, 54(2), 2001, pp. 267-268
Authors:
Assali, AR
Sdringola, S
Moustapha, A
Rihner, M
Denktas, AE
Lefkowitz, MA
Campbell, M
Smalling, RW
Citation: Ar. Assali et al., Endovascular repair of traumatic pseudoaneurysm by uncovered self-expandable stenting with or without transstent coiling of the aneurysm cavity, CATHET C IN, 53(2), 2001, pp. 253-258
Authors:
Nakagawa, Y
Nakagawa, K
Sdringola, S
Mullani, N
Gould, KL
Citation: Y. Nakagawa et al., A precise, three-dimensional atlas of myocardial perfusion correlated withcoronary arteriographic anatomy, J NUCL CARD, 8(5), 2001, pp. 580-590
Authors:
Moustapha, A
Assali, AR
Sdringola, S
Vaughn, WK
Fish, RD
Rosales, O
Schroth, G
Krajcer, Z
Smalling, RW
Anderson, HV
Citation: A. Moustapha et al., Percutaneous and surgical interventions for in-stent restenosis: Long-termoutcomes and effect of diabetes mellitus, J AM COL C, 37(7), 2001, pp. 1877-1882
Citation: S. Sdringola et al., High prevalence of myocardial perfusion abnormalities on positron emissiontomography in asymptomatic persons with a parent or sibling with coronary artery disease, CIRCULATION, 103(4), 2001, pp. 496-501
Authors:
Assali, AR
Salloum, J
Sdringola, S
Moustapha, A
Ghani, M
Hale, S
Schroth, G
Fujise, K
Anderson, HV
Smalling, RW
Rosales, OR
Citation: Ar. Assali et al., Effects of clopidogrel pretreatment before percutaneous coronary intervention in patients treated with glycoprotein IIb/IIIa inhibitors (abciximab ortirofiban), AM J CARD, 88(8), 2001, pp. 884
Authors:
Sdringola, S
Assali, A
Ghani, M
Yepes, A
Rosales, O
Schroth, GW
Fujise, K
Anderson, HV
Smalling, RW
Citation: S. Sdringola et al., Adenosine use during aortocoronary vein graft interventions reverses but does not prevent the slow-no reflow phenomenon, CATHET C IN, 51(4), 2000, pp. 394-399
Authors:
Assali, AR
Moustapha, A
Sdringola, S
Rihner, M
Smalling, RW
Citation: Ar. Assali et al., Successful treatment of coronary artery perforation in an abciximab-treated patient by microcoil embolization, CATHET C IN, 51(4), 2000, pp. 487-489
Authors:
Assali, AR
Sdringola, S
Ghani, M
Denkats, AE
Yepes, A
Hanna, GP
Schroth, G
Fujise, K
Anderson, HV
Smalling, RW
Rosales, OR
Citation: Ar. Assali et al., Intracoronary adenosine administered during percutaneous intervention in acute myocardial infarction and reduction in the incidence of "no reflow" phenomenon, CATHET C IN, 51(1), 2000, pp. 27-31
Authors:
Assali, AR
Sdringola, S
Ghani, M
Westbrook, LA
Anderson, HV
Schroth, G
Fujise, K
Smalling, RW
Rosales, OR
Citation: Ar. Assali et al., Timing of coronary stent thrombosis in patients treated with prophylactic tirofiban, J INVAS CAR, 12(9), 2000, pp. 460-463
Authors:
Gould, KL
Nakagawa, Y
Nakagawa, K
Sdringola, S
Hess, MJ
Haynie, M
Parker, N
Mullani, N
Kirkeeide, R
Citation: Kl. Gould et al., Frequency and clinical implications of fluid dynamically significant diffuse coronary artery disease manifest as graded, longitudinal, base-to-apex myocardial perfusion abnormalities by noninvasive positron emission tomography, CIRCULATION, 101(16), 2000, pp. 1931-1939